The relationship between neutrophil to lymphocyte ratio, endothelial function, and severity in patients with obstructive sleep apnea

Journal of cardiology
Jun-ichi OyamaKoichi Node

Abstract

Obstructive sleep apnea (OSA) is characterized by repetitive intermittent hypoxia and reoxygenation during sleep with elevated oxidative stress and promotes the development of atherosclerosis, as demonstrated by vascular dysfunction and chronic inflammation. An increased neutrophil to lymphocyte ratio (NLR) has been recognized to be a novel inflammatory biomarker for systemic inflammation. We evaluated whether the NLR reflects the severity of OSA and if continuous positive airway pressure (CPAP) treatment ameliorates the endothelial function and NLR in patients with OSA. We enrolled 95 patients with suspected OSA and 29 patients who received CPAP therapy for 3 months. We evaluated the number of endothelial progenitor cells (EPCs) and NLR, the levels of nitric oxide (NOx) and asymmetric dimethylarginine (ADMA), and the endothelial function according to the flow-mediated dilatation (FMD) before and after CPAP treatment. The levels of apnea-hypopnea index demonstrated an inverse relationship with the FMD and a positive relationship with the NLR. Moreover, NLR is an independent factor suggested for the presence of severe OSA. CPAP therapy increased the levels of EPC and NOx and decreased the level of ADMA. CPAP treatment also impro...Continue Reading

References

Mar 1, 1989·Circulation·J MehtaR Wallin
Oct 31, 1996·Nature·A K AbbasA Sher
Mar 15, 1997·The American Journal of Cardiology·S R OmmenS P Thomson
Apr 19, 2000·JAMA : the Journal of the American Medical Association·F J NietoT G Pickering
May 11, 2000·The New England Journal of Medicine·P E PeppardJ Skatrud
Sep 4, 2003·Circulation·Stephan BaldusUNKNOWN CAPTURE Investigators
Oct 9, 2003·JAMA : the Journal of the American Medical Association·Abu S M ShamsuzzamanVirend K Somers
May 17, 2005·Journal of the American College of Cardiology·Benjamin D HorneUNKNOWN Intermountain Heart Collaborative Study Group
Jun 6, 2006·Cytokine & Growth Factor Reviews·Dimitris TousoulisChristodoulos Stefanadis
Oct 9, 2007·Respiration; International Review of Thoracic Diseases·Mónica de la PeñaAlvar G N Agustí
May 24, 2008·Clinica Chimica Acta; International Journal of Clinical Chemistry·Angela PapaFranca Cocci
Sep 9, 2008·The American Journal of Cardiology·Umesh U TamhaneHitinder S Gurm
Jan 14, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Teruo InoueUNKNOWN Vascular Failure Workshop Group
Apr 24, 2010·Clinical Chemistry·Tobias ReichlinChristian Mueller
Sep 25, 2010·European Heart Journal·Marietta CharakidaJohn E Deanfield
Jan 25, 2011·The American Journal of Cardiology·Shanmugam UthamalingamRobert Capodilupo
Oct 13, 2011·Journal of Internal Medicine·N ArenjaC Mueller
Sep 3, 2013·American Journal of Respiratory and Critical Care Medicine·Richard J SchwabUNKNOWN ATS Subcommittee on CPAP Adherence Tracking Systems
Oct 3, 2013·Journal of cardiology·John S Floras
Feb 7, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Masato KajikawaYukihito Higashi
Jun 11, 2014·Scandinavian Cardiovascular Journal : SCJ·Anil AvciAli Metin Esen
Dec 3, 2014·The American Journal of Cardiology·Vicente A Benites-ZapataW H Wilson Tang

❮ Previous
Next ❯

Citations

Feb 9, 2018·Sleep & Breathing = Schlaf & Atmung·Moh'd Al-HalawaniMeir Kryger
Jan 11, 2020·Sleep & Breathing = Schlaf & Atmung·Jie LiuSongbai Lin
Jan 30, 2020·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Moh'd Al-HalawaniMohammad Al-Ajam
Sep 24, 2020·Mediators of Inflammation·Kamila BołtućAndrzej Jaroszyński
Dec 4, 2020·European Journal of Haematology·Johanna C Purdy, Joseph J Shatzel
Nov 6, 2018·Life Sciences·Hoda ElkhenanyNagwa El-Badri
Apr 17, 2021·Clinical and Experimental Hypertension : CHE·Ömer Faruk Çırakoğlu, Ahmet Seyda Yılmaz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.